Search
Design Therapeutics Inc
DSGNAdd to Watchlist
12.010USD
-0.170-1.40%
Close 07-31 16:00（ET）Quotes delayed by 15 min
749.92MMarket Cap
LossP/E TTM
Design Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Design Therapeutics Inc is 7.90, ranking 136 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.22, which is -84.94% below the recent high of -1.54 and -29.64% above the recent low of -13.24.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.